Goldman Sachs
SHACW

Goldman Sachs’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Goldman Sachs’s Portfolio SHACW Stock Details SHACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,645
Closed -$1K – 6522
2022
Q3 		$1K Hold
20,645
– – ﹤0.01% 6219
2022
Q2 		$2K Sell
20,645
-212
-1% -$30 ﹤0.01% 6402
2022
Q1 		$3K Hold
20,857
– – ﹤0.01% 6527
2021
Q4 		$11K Hold
20,857
– – ﹤0.01% 6415
2021
Q3 		$12K Hold
20,857
– – ﹤0.01% 6176
2021
Q2 		$18K Sell
20,857
-25,188
-55% -$16.1K ﹤0.01% 6148
2021
Q1 		$27K Buy
+46,045
New +$28.3K ﹤0.01% 5995

Goldman Sachs's SHACW Position: Q4 2022 in Review

Goldman Sachs sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 20,645 shares — an estimated $1K sold.

Goldman Sachs first reported a position in SHACW in Q1 2021 and held it in 7 quarters. The position peaked at $27K in Q1 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

  • Goldman Sachs reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 20,645 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $1K.
  • Goldman Sachs first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 7 quarters.
  • Goldman Sachs's SCP & CO Healthcare Acquisition Company Warrant position peaked at $27K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.